Upright T waves in lead aVR are associated with cardiac death or hospitalization for heart failure in patients with a prior myocardial infarction

Heart Vessels. 2012 Nov;27(6):548-52. doi: 10.1007/s00380-011-0193-6. Epub 2011 Oct 4.

Abstract

The aim of the present study was to clarify the prognostic significance of upright T waves (amplitude > 0 mV) in lead aVR in patients with a prior myocardial infarction (MI). We retrospectively examined 167 patients with a prior MI. The primary end point was cardiac death or hospitalization for heart failure. During a follow-up period of 6.5 ± 2.8 years, 34 patients developed the primary end point. A Kaplan-Meier analysis showed a lower primary event-free rate in patients with upright T waves in lead aVR than in those with nonupright T waves in lead aVR (P = 0.001). Univariate Cox proportional hazards regression analyses showed that age, gender, chronic kidney disease, anterior wall MI, upright T waves in lead aVR, left ventricular ejection fraction, loop diuretic use, and spironolactone use were significantly associated with the primary end point. A multivariate Cox proportional hazards regression analysis selected age [hazard ratio (HR) 1.10, 95% confidence interval (CI) 1.05-1.16, P < 0.001], upright T waves in lead aVR (HR 3.10, 95% CI 1.23-7.82, P = 0.017), and loop diuretic use (HR 4.61, 95% CI 1.55-13.67, P = 0.006) as independent predictors of the primary end point. In conclusion, the presence of upright T waves in lead aVR is an independent predictor of cardiac death or hospitalization for heart failure in patients with a prior MI. The analysis of T-wave amplitude in lead aVR provides useful prognostic information in patients with a prior MI.

MeSH terms

  • Age Factors
  • Aged
  • Anterior Wall Myocardial Infarction / complications
  • Anterior Wall Myocardial Infarction / diagnosis
  • Anterior Wall Myocardial Infarction / mortality*
  • Anterior Wall Myocardial Infarction / physiopathology
  • Chi-Square Distribution
  • Death, Sudden, Cardiac / etiology*
  • Disease-Free Survival
  • Electrocardiography*
  • Female
  • Heart Failure / diagnosis
  • Heart Failure / etiology
  • Heart Failure / mortality*
  • Heart Failure / physiopathology
  • Heart Failure / therapy
  • Hospitalization*
  • Humans
  • Kaplan-Meier Estimate
  • Male
  • Middle Aged
  • Mineralocorticoid Receptor Antagonists / therapeutic use
  • Multivariate Analysis
  • Predictive Value of Tests
  • Prognosis
  • Proportional Hazards Models
  • Renal Insufficiency, Chronic / mortality
  • Retrospective Studies
  • Risk Assessment
  • Risk Factors
  • Sex Factors
  • Sodium Potassium Chloride Symporter Inhibitors / therapeutic use
  • Spironolactone / therapeutic use
  • Stroke Volume
  • Time Factors
  • Ventricular Fibrillation / diagnosis
  • Ventricular Fibrillation / etiology
  • Ventricular Fibrillation / mortality*
  • Ventricular Fibrillation / physiopathology
  • Ventricular Function, Left

Substances

  • Mineralocorticoid Receptor Antagonists
  • Sodium Potassium Chloride Symporter Inhibitors
  • Spironolactone